Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabidiol as a Potential Treatment for Anxiety Disorders
Esther Blessing, Maria M. Steenkamp, Jorge Manzanares, et al.
Neurotherapeutics (2015) Vol. 12, Iss. 4, pp. 825-836
Open Access | Times Cited: 585

Showing 1-25 of 585 citing articles:

Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain
Danilo De Gregorio, Ryan J. McLaughlin, Luca Posa, et al.
Pain (2018) Vol. 160, Iss. 1, pp. 136-150
Open Access | Times Cited: 313
Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options
Amir Garakani, James W. Murrough, Rafael C. Freire, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 304
Medical cannabis access, use, and substitution for prescription opioids and other substances: A survey of authorized medical cannabis patients
Philippe Lucas, Zach Walsh
International Journal of Drug Policy (2017) Vol. 42, pp. 30-35
Closed Access | Times Cited: 236
The endocannabinoid system as a target for novel anxiolytic drugs
Sachin Patel, Mathew N. Hill, Joseph F. Cheer, et al.
Neuroscience & Biobehavioral Reviews (2017) Vol. 76, pp. 56-66
Open Access | Times Cited: 221
Cannabidiol: pharmacology and therapeutic targets
Stevie C. Britch, Shanna Babalonis, Sharon Walsh
Psychopharmacology (2020) Vol. 238, Iss. 1, pp. 9-28
Open Access | Times Cited: 220
Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science
Eric P. Baron
Headache The Journal of Head and Face Pain (2018) Vol. 58, Iss. 7, pp. 1139-1186
Closed Access | Times Cited: 211
Cannabis, cannabinoids, and health
Geneviève Lafaye, Laurent Karila, Lisa Blecha, et al.
Dialogues in Clinical Neuroscience (2017) Vol. 19, Iss. 3, pp. 309-316
Open Access | Times Cited: 210
Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders
María S. García‐Gutiérrez, Francisco Navarrete, Ani Gasparyan, et al.
Biomolecules (2020) Vol. 10, Iss. 11, pp. 1575-1575
Open Access | Times Cited: 210
Integrating Endocannabinoid Signaling and Cannabinoids into the Biology and Treatment of Posttraumatic Stress Disorder
Matthew N. Hill, Patrizia Campolongo, Rachel Yehuda, et al.
Neuropsychopharmacology (2017) Vol. 43, Iss. 1, pp. 80-102
Open Access | Times Cited: 202
Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review
Jerome Sarris, Justin Sinclair, Diana Karamacoska, et al.
BMC Psychiatry (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 201
The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases
Henry Lowe, Ngeh J. Toyang, Blair Steele, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9472-9472
Open Access | Times Cited: 198
Changing landscape of cannabis: novel products, formulations, and methods of administration
Tory R. Spindle, Marcel O. Bonn‐Miller, Ryan G. Vandrey
Current Opinion in Psychology (2019) Vol. 30, pp. 98-102
Open Access | Times Cited: 196
Industrial Hemp (Cannabis sativa subsp. sativa) as an Emerging Source for Value-Added Functional Food Ingredients and Nutraceuticals
H.P. Vasantha Rupasinghe, Amy Davis, Shanthanu Krishna Kumar, et al.
Molecules (2020) Vol. 25, Iss. 18, pp. 4078-4078
Open Access | Times Cited: 193
Diversity of molecular targets and signaling pathways for CBD
Douglas Lamounier de Almeida, Lakshmi A. Devi
Pharmacology Research & Perspectives (2020) Vol. 8, Iss. 6
Open Access | Times Cited: 192
Patient-reported use of medical cannabis for pain, anxiety, and depression symptoms: Systematic review and meta-analysis
Jesse D. Kosiba, Stephen A. Maisto, Joseph W. Ditre
Social Science & Medicine (2019) Vol. 233, pp. 181-192
Closed Access | Times Cited: 179
A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD)
Jiangling Peng, Mingjie Fan, Chelsea An, et al.
Basic & Clinical Pharmacology & Toxicology (2022) Vol. 130, Iss. 4, pp. 439-456
Open Access | Times Cited: 177
The “Entourage Effect”: Terpenes Coupled with Cannabinoids for the Treatment of Mood Disorders and Anxiety Disorders
Sari Goldstein Ferber, Dvora Namdar, Danielle Hen-Shoval, et al.
Current Neuropharmacology (2019) Vol. 18, Iss. 2, pp. 87-96
Open Access | Times Cited: 171
Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD)
Antonio Del Casale, Serena Sorice, Alessio Padovano, et al.
Current Neuropharmacology (2018) Vol. 17, Iss. 8, pp. 710-736
Open Access | Times Cited: 165
Anxiolytic Effects of Repeated Cannabidiol Treatment in Teenagers With Social Anxiety Disorders
Nobuo Masataka
Frontiers in Psychology (2019) Vol. 10
Open Access | Times Cited: 162
Cannabinoids, the endocannabinoid system, and pain: a review of preclinical studies
David P. Finn, Simon Haroutounian, Andrea G. Hohmann, et al.
Pain (2021) Vol. 162, Iss. 1, pp. S5-S25
Open Access | Times Cited: 162
Dosage, Efficacy and Safety of Cannabidiol Administration in Adults: A Systematic Review of Human Trials
Christian Larsen, Jorida Shahinas
Journal of Clinical Medicine Research (2020) Vol. 12, Iss. 3, pp. 129-141
Open Access | Times Cited: 147
The Polypharmacological Effects of Cannabidiol
Jorge Iván Castillo-Arellano, Ana Canseco-Alba, Stephen J. Cutler, et al.
Molecules (2023) Vol. 28, Iss. 7, pp. 3271-3271
Open Access | Times Cited: 70
Selective Cannabinoids for Chronic Neuropathic Pain: A Systematic Review and Meta-analysis
Howard Meng, Bradley C. Johnston, Marina Englesakis, et al.
Anesthesia & Analgesia (2017) Vol. 125, Iss. 5, pp. 1638-1652
Closed Access | Times Cited: 146
Cannabidiol (CBD) use in psychiatric disorders: A systematic review
Stefania Bonaccorso, A Ricciardi, Caroline Zangani, et al.
NeuroToxicology (2019) Vol. 74, pp. 282-298
Open Access | Times Cited: 142
Cannabidiol regulation of emotion and emotional memory processing: relevance for treating anxiety‐related and substance abuse disorders
Jonathan Lee, Leandro J. Bertoglio, Francisco Silveira Guimarães, et al.
British Journal of Pharmacology (2017) Vol. 174, Iss. 19, pp. 3242-3256
Open Access | Times Cited: 132
Page 1 - Next Page

Scroll to top